Scholars Central

Conference abstractPublished 12 Sep 2016

Effect of SERCA gene modified stem cells on functional recovery of diabetic cardiomyopathy

Authors: L A Kassem, Y Safwat, N A Yassin, M A Gamal El Din, M S Fadel, M B Zekri, S G Abo Elfadl, M I Khairallah

German University in Cairo, Egypt Cairo University, Egypt Animal Reproduction Research Institute, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This study addressed the potential application of genetically modified mesenchymal stem cells (MSCs) with sarcoplasmic reticulum Ca+2 ATPase2a (SERCA2a) gene in treatment of diabetic cardiomyopathy (DC) focusing on the role of (SERCA2a) in the pathogenesis of such dysfunction. 40 rats were divided into four groups: Control (group one), DC (group two), DC treated with either MSCs (group three) or genetically modified MSCs with SERCA2a (group four). Serum glucose, insulin and HOMA index were measured. Echocardiography studies were performed; {(left ventricular dimension at systole (LVDs) and diastole (LVDd), ejection fraction (EF) and fraction shortening (FS)}. Gene expression of SERCA2a, IGF1, troponin T and immunostaining of both connexin 43 and CD105 as well as histomorphometric study were assessed in cardiac muscles. DC group showed structural and functional abnormalities in myocardium. DC group treated with modified MSCs with SERCA2a showed higher cardiac expression of SERCA2a than DC groups untreated and treated with MSCs. IGF1 and troponin T were more upregulated in group four than group two. There was significant reduction in LVDs and LVDd and significant increase in EF and FS in the modified treated DC group compared to DC group. EF and FS, major indices of systolic function were almost normalized in group four. Area percentage of degenerated cardiomyocytes was significantly decreased in group four than groups two and three and connexin 43 was highly immunoexpressed. The use of genetically modified MSCs with SERCA2a restore the altered cardiac structure and function and provide novel promising strategy for treatment of DC.

Subjects

Engineering

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Tissue Science and Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Tissue Science and Engineering
  • SubjectEngineering
  • BylineArticles whose byline prints “L A Kassem”
  • BylineArticles whose byline prints “Y Safwat”
  • BylineArticles whose byline prints “N A Yassin”
  • BylineArticles whose byline prints “M A Gamal El Din”
  • BylineArticles whose byline prints “M S Fadel”
  • BylineArticles whose byline prints “M B Zekri”
  • BylineArticles whose byline prints “S G Abo Elfadl”
  • BylineArticles whose byline prints “M I Khairallah”